dkk 1,241.00
Updated 23/02/2018
Change % 0.00% Stock price unchanged
Change 0.00 Stock price unchanged
Volume 0
High DKK 0
Low DKK 0
Open DKK0
ISIN DK0010272202
Prev close DKK1,200.00
# of shares 61.19M
Market cap 75,931M DKK
Intraday

Market closed
Genmab A/S
Market is closed, opens at 08:00
 
Price development Latest 1 week 1 month 3 months 6 months 1 year
 
  1,241.00 14.1% Stock price increasing 12.9% Stock price increasing 3.8% Stock price increasing -11.4% Stock price decreasing -9.5% Stock price decreasing
Key Figures (m DKK)
Turnover
EBIT
Net Profit
Equity
Balance
2015
1,133
730
764
3,487
3,903
2014
850
265
301
2,032
2,866
2013
664
69
112
660
1,732
2012
485
-117
-487
383
1,693
2011
351
-249
-596
486
1,564
2010
582
-161
-321
1,080
2,482
2009
586
0
-1,011
1,297
2,222
2008
745
-870
-965
2,189
0
2007
530
-437
-383
2,883
0
Powered by TradingView

News about Genmab A/S

  • English
  • Regulatory news

Related

Latest 1 week 1 month 3 months 6 months 1 year
YTD
 
Competitors Open
 
Eisai CO Ltd 43.41 4.7% Stock price increasing -6.4% Stock price decreasing -6.2% Stock price decreasing 0.3% Stock price increasing 42.3% Stock price increasing -9.9% Stock price decreasing
 
Bristol-Myers Squibb Company 67.95 -1.5% Stock price decreasing 7.0% Stock price increasing 10.6% Stock price increasing 16.4% Stock price increasing 20.4% Stock price increasing 10.9% Stock price increasing
 
Johnson & Johnson 132.02 -0.8% Stock price decreasing -8.6% Stock price decreasing -4.3% Stock price decreasing 0.3% Stock price increasing 7.6% Stock price increasing -5.5% Stock price decreasing
 
Pfizer Inc 36.26 0.0% Stock price unchanged -2.6% Stock price decreasing 2.2% Stock price increasing 8.6% Stock price increasing 5.8% Stock price increasing 0.1% Stock price increasing
 
Amgen Inc 186.67 1.7% Stock price increasing -1.8% Stock price decreasing 9.7% Stock price increasing 10.0% Stock price increasing 6.9% Stock price increasing 7.3% Stock price increasing
 
Bavarian Nordic A/S 242.60 -0.9% Stock price decreasing 4.1% Stock price increasing 2.6% Stock price increasing -43.6% Stock price decreasing -14.3% Stock price decreasing 8.2% Stock price increasing
 
Merck Kgaa O.N. 82.34 -1.4% Stock price decreasing -8.0% Stock price decreasing -7.6% Stock price decreasing -11.3% Stock price decreasing -20.2% Stock price decreasing -8.3% Stock price decreasing
 
Novartis NAM SF 0,50 69.22 -1.3% Stock price decreasing -7.5% Stock price decreasing -3.0% Stock price decreasing -1.9% Stock price decreasing -4.8% Stock price decreasing -2.0% Stock price decreasing
 
Roche Hldg AG GEN 192.40 -1.6% Stock price decreasing -2.4% Stock price decreasing -8.4% Stock price decreasing -9.8% Stock price decreasing -17.1% Stock price decreasing -8.6% Stock price decreasing
 
Biogen Inc 292.78 0.3% Stock price increasing -17.2% Stock price decreasing -5.2% Stock price decreasing 2.7% Stock price increasing 2.7% Stock price increasing -8.1% Stock price decreasing
 
Emergent Biosolutions Inc 46.87 -6.2% Stock price decreasing -7.7% Stock price decreasing 12.5% Stock price increasing 30.9% Stock price increasing 56.5% Stock price increasing 0.9% Stock price increasing
 
Bayer AG NA O.N. 97.92 -0.6% Stock price decreasing -8.2% Stock price decreasing -9.1% Stock price decreasing -10.2% Stock price decreasing -6.1% Stock price decreasing -5.8% Stock price decreasing
Indices Open
 
OMX Copenhagen 20 CAP 1,149.43 0.8% Stock price increasing 0.8% Stock price increasing 3.5% Stock price increasing -1.5% Stock price decreasing 7.9% Stock price increasing 0.5% Stock price increasing

Company profile

Genmab is a leading international biotechnology company located in Denmark. They focus on developing medication for cancer treatments. Genmab uses advanced technology to create and develop products to address unmet medical needs.

Peers

Indices Last Change  
OMX C20 Cap 1,149.43 0.0% Stock price unchanged
13,25,24,5,25,35,70,99,72,85
Instruments Last Change  
Eisai CO Ltd 43.41 0.0% Stock price unchanged
0,0,0,0,0,100,100,100,100,100
Bristol-Myer.. 67.95 0.0% Stock price unchanged
Johnson & Jo.. 132.02 0.0% Stock price unchanged
Pfizer Inc 36.26 0.0% Stock price unchanged
Amgen Inc 186.67 0.0% Stock price unchanged
29,15,7,21,25,26,28,71,81,99
Bavarian Nor.. 242.60 0.0% Stock price unchanged
0,35,15,0,35,62,86,57,71,50
Merck Kgaa O.. 82.34 0.0% Stock price unchanged
Novartis NAM.. 69.22 0.0% Stock price unchanged
Roche Hldg A.. 192.40 0.0% Stock price unchanged
Biogen Inc 292.78 0.0% Stock price unchanged
48,19,27,35,21,36,35,74,82,84
Emergent Bio.. 46.87 0.0% Stock price unchanged
Bayer AG NA .. 97.92 0.0% Stock price unchanged

Targets for: Genmab A/S

Ritzau Finans
 
Analyst
Target
Date
Genmab/Carnegie: Kursmålet sænkes til 1210 kr. fra 1392 kr.
Carnegie
1,210
19/12/17
Genmab/ABG: Sænker kursmål til 1430 kr. men gentager
ABG Sundal Collier
1,430 ned
18/12/17
Genmab/Jyske: Kursmålet trimmes til 1600 kr. - NY
Jyske Bank
1,600
15/12/17
Genmab/Jyske: Kursmålet trimmes til 1600 kr.
Jyske Bank
1,600
15/12/17
Genmab/Citi: Kursmålet bliver løftet til 1800 kr. - citat
Citigroup
1,800 op
01/06/17

Copyright Euroinvestor A/S 2018   Disclaimer and Terms of Use
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
25 February 2018 01:40:40
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: ReleaseBuild_20180222.1 - EUROWEB5 - 2018-02-25 02:40:40 - 2018-02-25 01:40:40 - 1000 - Website: OKAY